Liz has spent more than two decades building research initiatives and collaborations with non-profit organizations, with a focus on registries and biobanks. Over the past decade, she has become a critical force in increasing research and knowledge about Lyme disease and is a highly-respected national expert in tick-borne disease. Liz was part of the team that launched the Lyme Disease Biobank, which was created to provide much-needed samples to researchers studying Lyme disease and other tick-borne infections, and has supported more than 20 published studies to date. She has mentored numerous researchers and has been invited as an advisor on several U.S. government efforts. Since 2020, she has served as a scientific advisor for the LymeX Diagnostics Prize, a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation. She also served on the Diagnostic Subcommittee of the HHS Tick-Borne Disease Working Group in 2021 and 2022 and has been a member of the programmatic panel for the Congressionally Directed Medical Research Programs (CDMRRP) Tick-Borne Disease Research Program (TBDRP) since 2023. Liz earned her doctorate in molecular pharmacology and cancer therapeutics from SUNY at Buffalo, was a National Library of Medicine fellow in biomedical informatics and received her MBI from Oregon Health & Science University. Liz is passionate about building resources to move research forward that help people, improve lives, and reduce suffering.